5-Bromouracil , 99% , 51-20-7
Synonym(s):
5-Bromo-2,4-dihydroxypyrimidine
CAS NO.:51-20-7
Empirical Formula: C4H3BrN2O2
Molecular Weight: 190.98
MDL number: MFCD00006017
EINECS: 200-084-0
Pack Size | Price | Stock | Quantity |
5G | RMB28.00 | In Stock |
|
25G | RMB68.00 | In Stock |
|
100G | RMB223.20 | In Stock |
|
500g | RMB959.20 | In Stock |
|
others | Enquire |
PRODUCT Properties
Melting point: | >300 °C (lit.) |
Density | 1.8710 (rough estimate) |
refractive index | 1.6200 (estimate) |
storage temp. | Keep in dark place,Sealed in dry,Room Temperature |
solubility | <1g/l |
pka | 6.77±0.10(Predicted) |
form | Solid |
color | White |
Water Solubility | SOLUBLE IN COLD WATER |
Merck | 14,1445 |
BRN | 127176 |
InChIKey | LQLQRFGHAALLLE-UHFFFAOYSA-N |
Description and Uses
5-bromouracil (5-BU) is a uracil derivative, and its 5' position of the pyrimidine ring is halogenated. If 5-BU is incorporated into DNA in place of thymine, the tautomeric shift will occur, and the 5-BU will base pair with guanine. After the replication, an A-T to G-C transition occurs. Furthermore, the presence of 5-BU within DNA increases the sensitivity of the molecule to UV light. 5-BU is structurally similar to thymine. Therefore, it is considered a thymine analog and base-pairs normally with adenine. It is rarely present in its enol form, where its base pairs with guanine. 5-Bromouracil treats neoplasms in the form of its nucleoside, 5-bromo-2-deoxy-uridine[1-2].
A major chemical mutagen. Incorporates into DNA, altering base-pair sequencing by replacing thymine
Safety
Symbol(GHS) | GHS08 |
Signal word | Warning |
Hazard statements | H341 |
Precautionary statements | P201-P202-P280-P308+P313-P405-P501a |
Hazard Codes | Xn |
Risk Statements | 22-46 |
Safety Statements | 36/37-53-45-24/25 |
WGK Germany | 3 |
RTECS | YQ9060000 |
TSCA | Yes |
HS Code | 29335995 |